Innovation in the Life Sciences industry is under immense pressure. How do you invest your resources to secure your spot on the playing field? Gain insights from MedtechPartners, imec, Cochlear and Verhaert on how to solve 4 recurring challenges in medical innovation during the Life Sciences Paradox event on Thursday September 22nd.
Facing the innovation paradox in Life Sciences
Innovation is vitally important to Life Sciences. However, the industry is traditionally confronted by lower market adoption rates, tighter restrictions and regulations. The current crisis now also causes increased competition and budget cuts. This forces medical companies to face a tough paradox. How will they invest their resources?
On the one hand, they can stay focused on current product lines, technologies and methodologies. This implies fewer risks but can limit disruptive innovation. On the other hand, they can start focusing on longer-term preventative, personalized and value-based healthcare. An approach with more risks and a higher potential to truly differentiate from competitors.
Unlocking your medical innovation potential
A paradox isn’t easy to resolve, and this one in particular has many facets. That’s why we divided it into 4 inspirational sessions, each one tackling a recurring challenge. During the Life Science Paradox event, you’ll gain insights from MedtechPartners, imec, Cochlear and Verhaert on how to successfully overcome the paradox in their innovation:
- 10h00 – The reimbursement paradox (MedtechPartners)
- 10h35 – The R&D paradox (imec)
- 11h10 – The digital paradox (Verhaert)
- 11h40 – The user insights paradox (Cochlear)
Interested in the Life Sciences Paradox event on September 22nd? Visit the event page to register or find more information about the sessions. You can attend this event online or physically at the Verhaert offices in Kruibeke.
